Status: current, Primitive. Date: 30-Jun 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 137351000036118 | Topotecan (Kabi) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 137361000036115 | Topotecan (Kabi) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Topotecan (Kabi) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Topotecan (Kabi) 4 mg powder for injection, 4 mg vial | Is a | True | Topotecan (Kabi) | Inferred relationship | Some | |
| Topotecan (Kabi) 4 mg powder for injection, 5 vials | has TP | True | Topotecan (Kabi) | Inferred relationship | Some | |
| Topotecan (Kabi) 4 mg powder for injection, 1 vial | has TP | True | Topotecan (Kabi) | Inferred relationship | Some | |
| Topotecan (Kabi) 4 mg powder for injection, 5 vials | has TP | True | Topotecan (Kabi) | Inferred relationship | Some | |
| Topotecan (Kabi) 4 mg powder for injection, 1 vial | has TP | True | Topotecan (Kabi) | Inferred relationship | Some |
Reference Sets
FHIR